Further, knockdown of ADORA2A-AS1 inhibited the proliferation, induced apoptosis, arrested cell cycle, and enhanced imatinib sensitivity in CML cells. The gene discussed is ADORA2A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.